scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1039355275 |
P356 | DOI | 10.2165/00019053-200422002-00009 |
P698 | PubMed publication ID | 15660480 |
P50 | author | Jerry Avorn | Q6183214 |
P2860 | cites work | The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 |
Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme | Q33903908 | ||
Internet marketing of herbal products | Q34234317 | ||
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture | Q34268922 | ||
Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center | Q34329929 | ||
A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction | Q43589900 | ||
Quality indicators for appropriate medication use in vulnerable elders | Q43767405 | ||
New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population | Q43854293 | ||
Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? | Q44704673 | ||
A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. | Q52042533 | ||
Long-term persistence in use of statin therapy in elderly patients | Q74497691 | ||
An economic evaluation of activated protein C treatment for severe sepsis | Q77221911 | ||
P433 | issue | 2 Suppl 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 81-86 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | PharmacoEconomics | Q7180778 |
P1476 | title | The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation | |
P478 | volume | 22 |
Search more.